跳至主要内容
临床试验/CTRI/2020/12/030107
CTRI/2020/12/030107进行中(未招募)4 期

A COMPARATIVE STUDY TO INVESTIGATE THE EFFECT OF VAMANA KARMA AND TRIPHALA AND GUDUCHI CHURNA WITH MADHU ON GUT MICROBIOTA AND METABOLITE PATTERNS IN PRAMEHA W.S.R TO TYPE 2 DIABETES MELLITUS AND HEALTHY INDIVIDUALS.

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • For Prameha(Type 2 Diabetes Mellitus) Individuals-
  • 1. BMIââ?°Â¥ 20
  • 2. Kaphaj/Kapha-pittaj Vikriti predominant individuals
  • 3. Diagnosed cases of Prameha/Madhumeha/T2DM with either of the following-
  • a) Fasting plasma glucose values of ââ?°Â¥ 7.0 mmol/L (126 mg/dl)
  • b) 2-h post-load plasma glucose ââ?°Â¥ 11.1 mmol/L (200 mg/dl)
  • c) HbA1c ââ?°Â¥ 6.5% (48 mmol/mol)
  • d) Random blood glucose ââ?°Â¥ 11.1 mmol/L (200 mg/dl)
  • 4. Chronicity: Up to 10 years
  • For Healthy Individuals
  • 1. BMIââ?°Â¥ 20
  • 2. Kaphaj/Kapha-pittaj Prakriti predominant Individuals as per Proforma for Prakriti Assessment by CSIR Ayurgenomics Unit- TRISUTRA CSIR-IGIB, NEW DELHI
  • 3. Healthy individuals as per Proforma for Health Assessment by self-reporting of CSIR Ayurgenomics Unit- TRISUTRA CSIR-IGIB, NEW DELHI

排除标准

  • Patients unfit for Snehana(Internal Oleation), Svedana(Sudation), Vamana(therapeutically induced emesis for internal bio-cleansing).
  • For Prameha(Type 2 Diabetes Mellitus)-
  • 1. Patients with T2 DM exceeding the following plasma glucose limits-
  • a) Fasting plasma glucose values of ââ?°Â¥ 300mg/dL
  • b) 2-h post-load plasma glucoseââ?°Â¥400mg/dL
  • c) Random blood glucoseââ?°Â¥ 400mg/dL
  • 2. Chronicity: More than 10 years.
  • 3. Known cases of Severe systemic diseases like- Cardiac disease, pulmonary tuberculosis, severe lung disease, uncontrolled diabetes and pregnant women.

研究者

相似试验